CellCentric
PrivateLast Round
Series D
May 6, 2026
Est. Valuation
$900M
Total Funding Raised
$476.74M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellCentric is a biotechnology company specializing in clinical-stage cancer therapies that develop innovative small-molecule inhibitors targeting specific cancers, including relapsed refractory multiple myeloma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellCentric Comps
Public and private peers based on sector, stage, and business model.
CellCentric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 6, 2026 | ||||
| Series C | May 19, 2025 | ||||
| Series C | Jul 24, 2024 | ||||
| Convertible Debt | Jul 11, 2023 | ||||
| Series C | Jan 26, 2022 | ||||
Early Funding | Oct 22, 2020 |
Key People
Founding team and executive leadership
CellCentric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series D, Series C |
| Forbion Capital Partners | Series C |
| RA Capital Management | Series D, Series C |
| Future Planet Capital Regional | Grant |
| Forbion | Series D, Series C |
| BrightEdge | Series C |
| Morningside Ventures | Series C, Series B, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$220M round led by Venrock.
- Dec 19, 2025
Inobrodib enters Phase 3 trial for multiple myeloma and other cancers.
CellCentric Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellCentric's valuation, stock price, and market status.
